Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 4:02 AM ET


Company Overview of Five Prime Therapeutics, Inc.

Key Executives for Five Prime Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Lewis T. Williams M.D., Ph.D.47 RelationshipsFounder, Chief Executive Officer, President and Director66
Marc L. Belsky No RelationshipsChief Financial Officer and Senior Vice President60
Kevin P. Baker Ph.D.No RelationshipsSenior Vice President of Development Sciences--
Julie Hambleton M.D. No RelationshipsChief Medical Officer and Executive Vice President57
Aron Marc Knickerbocker 20 RelationshipsChief Business Officer, Executive Vice President and Director46
View More Key Executives

Five Prime Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Brian G. Atwood MBA 228 RelationshipsVersant Ventures, Inc.62
Lewis T. Williams M.D., Ph.D. 47 RelationshipsFive Prime Therapeutics, Inc.66
Aron Marc Knickerbocker 20 RelationshipsFive Prime Therapeutics, Inc.46
Mark D. McDade 59 RelationshipsUCB S.A.60
Franklin M. Berger CFA, BA, MA, MBA 112 RelationshipsFive Prime Therapeutics, Inc.65
View All Board Members

Five Prime Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger112 Relationships3 Executives
Compensation Committee Mark D. McDade59 Relationships3 Executives
Nominating Committee M.D.Peder K. Jensen40 Relationships4 Executives
Corporate Governance Committee M.D.Peder K. Jensen40 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$525.0K
Total Value of Options
Compensation as of Fiscal Year
Five Prime Therapeutics, Inc. CEO Compensation
Industry Average


Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at